Author:
Desta Beza Zewdu,Dadi Abel Fekadu,Derseh Behailu Tariku
Abstract
Abstract
Background
The prevalence of chronic kidney disease (CKD) is between 10 and 15% worldwide. Ethiopia is seeing a consistent increase in the number of dialysis patients. Patients on chronic hemodialysis have high mortality rates, but there is little information available in Ethiopia. Thus, this study looked into patient mortality and the factors that contributed to it at three dialysis centers in Addis Ababa for hemodialysis patients.
Method
A facility-based retrospective follow-up study was employed among End-Stage Renal Disease patients on hemodialysis from 2016 to 2020 at St. Paul Millennium Medical College (SPMMC), Zewditu Memorial Hospital (ZMH), and Menelik II Hospital. The proportional hazard assumption was checked by using the Log (-log (St)) plots and tests. Life-table analysis was fitted to estimate the one and five-year’s survival probability of these patients and Cox Proportional regression analysis to model the predictors of mortality at p-value < 0.05.
Result
Over the course of 2772 person-months, 139 patients were tracked. Of these patients, 88 (63.3%) were male and the mean age (± SD) of the patients was 36.8 (± 11.9) years. During the follow-up period, 24 (17%) of the patients died, 67 (48.2%) were alive, 43 (30.9%) received a kidney transplant, and 5 (3.6%) were lost to follow-up. The mean survival time was 46.2 months (95% CI: 41.8, 50.5). According to estimates, there were 104 deaths per 1000 person-years at the end of the follow-up period. The likelihood that these patients would survive for one and 5 years was 91%% and 65%, respectively. Our analysis showed that patients with hypertension (Adjusted Hazard Rate (AHR) = 4.33; 95% CI: 1.02, 34.56), cardiovascular disease (AHR = 4.69; 95% CI: 1.32, 16.80), and infection during dialysis (AHR = 3.89; 95% CI: 1.96, 13.80) were more likely to die.
Conclusion
The hemodialysis patients' death rate in the chosen dialysis facilities was high. Preventing and treating comorbidities and complications during dialysis would probably reduce the mortality of CKD patients. Furthermore, the best way to avoid and manage chronic kidney disease is to take a complete and integrated approach to manage hypertension, diabetes, and obesity.
Publisher
Springer Science and Business Media LLC
Reference29 articles.
1. Jha V, Garcia-garcia G, Iseki K, Li Z, Naicker S, Plattner B, et al. Global kidney disease 3 chronic kidney disease : global dimension and perspectives. Lancet. 2013;382(9888):260–72.
2. Couser WG, Remuzzi G, Mendis S, Tonelli M. The contribution of chronic kidney disease to the global burden of major noncommunicable diseases. Kidney Int. 2011;80(12):1258–70.
3. International Society of Nephrology. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Off J Int Soc Nephrol. 2013;3(1):163.
4. Milik A, Hrynkiewicz E, KDIGO 2012. Clinical practice guideline for the evaluation and management of chronic kidney disease. kidney international supplements. J Int Soc Nephrol. 2013;158(11):825–30.
5. Kore C, Tadesse A, Teshome B, Daniel K, Kassa A, Ayalew D. The magnitude of chronic kidney disease and its risk factors at Zewditu Memorial Hospital, Addis Ababa, Ethiopia. J Nephrol Ther. 2018;08(03):313.